Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05539430
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more
Legend Biotech USA Inc 56
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Looking for participantsNCT05772208
What this trial is testing

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 459
Large-scale testing (Phase 3)Looking for participantsNCT06256588
What this trial is testing

Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 864
Early research (Phase 1)Study completedNCT00004246
What this trial is testing

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 16
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT00798655
What this trial is testing

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer

Who this might be right for
Cancer of HeadCancer of Head and NeckCancer of Neck+15 more
Robert Ferris 46
Testing effectiveness (Phase 2)WithdrawnNCT00084435
What this trial is testing

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT00410761
What this trial is testing

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Genzyme, a Sanofi Company 331
Testing effectiveness (Phase 2)Study completedNCT00498953
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 7
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07550972
What this trial is testing

Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Zhejiang Provincial People's Hospital 30
Large-scale testing (Phase 3)Study completedNCT00704730
What this trial is testing

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Exelixis 330
Testing effectiveness (Phase 2)UnknownNCT02016417
What this trial is testing

Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University 120
Large-scale testing (Phase 3)Study completedNCT00609284
What this trial is testing

Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 406
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209
What this trial is testing

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more
Seagen, a wholly owned subsidiary of Pfizer 350
Testing effectiveness (Phase 2)Looking for participantsNCT06601309
What this trial is testing

Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital 90
Testing effectiveness (Phase 2)Ended earlyNCT01128387
What this trial is testing

Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer

Who this might be right for
Cancer
University of Wisconsin, Madison 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05787639
What this trial is testing

Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)

Who this might be right for
Oropharynx Cancer
University of California, San Diego 28
Testing effectiveness (Phase 2)UnknownNCT05896787
What this trial is testing

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 45
Testing effectiveness (Phase 2)Looking for participantsNCT06682793
What this trial is testing

Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more
A2 Biotherapeutics Inc. 240
Next Page